SCHEMBL1976429

SCHEMBL1976429

O=COC1(NC(=O)c2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
APAF1 O14727 1/20 0.47
TDP2 O95551 1/20 0.47
NSD2 O96028 1/20 0.47
ABL1 P00519 1/20 0.47
HSP90AA1 P07900 1/20 0.47
HSP90AB1 P08238 1/20 0.47
CASP3 P42574 1/20 0.47
HTT P42858 1/20 0.47
GALK1 P51570 1/20 0.47
BLM P54132 1/20 0.47
PPP1CA P62136 1/20 0.47
RIN1 Q13671 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11609600 0.81 ALDH1A1 (0.54) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL11608129 0.80 HSD17B10 (0.59) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL3645705 0.72 ALDH1A1 (0.44) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL27848880 0.72 HSD17B10 (0.59) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL11609043 0.72 FAAH (0.58) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL5585773 0.71 CTSK (0.48) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL12987195 0.71 FAAH (0.51) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL1740329 0.71 CTSL (0.53) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL5675474 0.70 FAAH (0.56) ALDH1A1KDM4EFAAHRAB9A
SCHEMBL12889173 0.70 ADRB2 (0.43) ALDH1A1MAPTKMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509981-B1 INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE LILLY CO ELI (US) 2014-08-06 EP disclosed
US-8299061-B2 Inhibitors of diacylglycerol acyltransferase ELI LILLY AND COMPANY (US) 2012-10-30 US disclosed
US-20110144091-A1 Inhibitors of Diacylglycerol Acyltransferase ELI LILLY AND COMPANY (US) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144091-A1 Inhibitors of Diacylglycerol Acyltransferase DGAT1, DGAT2, LCAT ALDH1A1 691/4885MAPT 2456/4885KMT2A 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.